OOIR: Observatory of International Research

Papers

(The H4-Index of Neural Regeneration Research is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Generating oligodendroglia from adult mesenchymal cells for transplantation: cell reprogramming or direct lineage conversion?	228
Increased retinal venule diameter as a prognostic indicator for recurrent cerebrovascular events: a prospective observational study	162
Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons	119
Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics	108
The circ_0002538/miR-138-5p/plasmolipin axis regulates Schwann cell migration and myelination in diabetic peripheral neuropathy	98
SCFD1 in amyotrophic lateral sclerosis: reconciling a genetic association with in vivo functional analysis	93
Dual-targeting AAV9P1-mediated neuronal reprogramming in a mouse model of traumatic brain injury	90
Functions of nuclear factor Y in nervous system development, function and health	87
Rbm8a regulates neurogenesis and reduces Alzheimer’s disease-associated pathology in the dentate gyrus of 5×FAD mice	76
Exercise-with-melatonin therapy improves sleep disorder and motor dysfunction in a rat model of ischemic stroke	75
Prolonged intermittent theta burst stimulation restores the balance between A2AR- and A1R-mediated adenosine signaling in the 6-hydroxidopamine model of Parkinson’s disease	73
Porcine decellularized nerve matrix hydrogel attenuates neuroinflammation after peripheral nerve injury by inhibiting the TLR4/MyD88/NF-κB axis	71
Protocadherin gamma C3: a new player in regulating vascular barrier function	71
Could inorganic polyphosphate be a valid target against neuronal senescence?	68
Neuromodulation techniques for modulating cognitive function: Enhancing stimulation precision and intervention effects	66
Tropism-shifted AAV-PHP.eB-mediated bFGF gene therapy promotes varied neurorestoration after ischemic stroke in mice	63
Rapamycin as a preventive intervention for Alzheimer’s disease in APOE4 carriers: Targeting brain metabolic and vascular restoration	62
Beyond apoptosis: Implications of annexin-V binding to myeloid cells in DARC (Detection of Apoptosing Retinal Cells) imaging	61
Delayed microglial depletion protects against white matter injury following neonatal cerebral hemorrhage in mice	60
Telomere length as a predictive marker for long-term cognitive function in a mouse model of subarachnoid hemorrhage	59
Intriguing role of the Golgi apparatus in astrocyte function: Implications for disorders	57
The intrinsic excitability of and autophagy protein expression levels in dentate gyrus ensembles regulate fear generalization	57
FKBP51: A new target for Parkinson’s disease	57
Activation of medial septum cholinergic neurons restores cognitive function in temporal lobe epilepsy	57
Stepping up after spinal cord injury: negotiating an obstacle during walking	56

Activity-dependent regulation of cortical cell numbers: Role of neuronal activity in cortical circuit formation	53
Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases	53
Potential common pathogenesis of several neurodegenerative diseases	52
Krüppel-like factor 2 (KLF2), a potential target for neuroregeneration	52
Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway	52
LL-37 and CsgC exemplify the crosstalk between anti-amyloid, antimicrobial, and anti-biofilm protein activities	51
Human endogenous retrovirus type-W and multiple sclerosis–related smoldering neuroinflammation	51
Role of copper chelating agents: between old applications and new perspectives in neuroscience	51
Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety	50
Neuroserpin alleviates cerebral ischemia-reperfusion injury by suppressing ischemia-induced endoplasmic reticulum stress	50
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disorders	49
Role of the globus pallidus in motor and non-motor symptoms of Parkinson’s disease	49
NECAB family of neuronal calcium-binding proteins in health and disease	49
The complex roles of m6A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseases	48
Neurogenesis dynamics in the olfactory bulb: deciphering circuitry organization, function, and adaptive plasticity	48
Ethanol changes Nestin-promoter induced neural stem cells to disturb newborn dendritic spine remodeling in the hippocampus of mice	48
Selective deletion of zinc transporter 3 in amacrine cells promotes retinal ganglion cell survival and optic nerve regeneration after injury	47
Injectable collagen scaffold with human umbilical cord-derived mesenchymal stem cells promotes functional recovery in patients with spontaneous intracerebral hemorrhage: phase I clinical trial	47
Autolysosomal acidification impairment as a mediator for TNFR1 induced neuronal necroptosis in Alzheimer's disease	47
Eph receptor A4 regulates motor neuron ferroptosis in spinal cord ischemia/reperfusion injury in rats	46
Astrocyte chloride, excitatory-inhibitory balance and epilepsy	46
Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis	46
Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes	46
Chx10+V2a interneurons in spinal motor regulation and spinal cord injury	46
Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder	46
Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury	46